The global disposable plastic blood bag market is growing, due to increasing prevalence of chronic diseases and rising aging population. In addition, rising initiatives undertaken by government associations to boost awareness about blood donations and advanced features of disposable plastic blood bags are also driving the growth of the global disposable plastic blood bag market.
Request for report sample at: https://www.psmarketresearch.com/market-analysis/disposable-plastic-blood-bag-market/report-sample
Increasing prevalence of various chronic diseases, such as cancer and blood disorders, is playing a pivotal role in the growth of disposable plastic blood bag market. Additionally, increased participation of government associations had raised awareness regarding blood donations all over the world. Some of the major associations include the World Health Organization (WHO), International Federation of Red Cross and Red Crescent Societies (IFRC), and American Red Cross. These organizations support blood donation programs and encourage people to donate blood and blood components.
Geographically, North America dominated the global disposable plastic blood bag market in 2014; and it is expected to grow at a CAGR of 9.4% during the period 2015 – 2020. However, the Asian disposable plastic blood bag market is expected to witness fastest growth, with a CAGR of 9.8% during the forecast period.
The key companies operating in the global disposable plastic blood bag market include Haemonetics Corporation, JMS Co., Ltd., Kawasumi Laboratories, Inc., Grifols International S.A., AdvaCare Pharma, Fresenius SE & Co. KGaA, Terumo Corporation, Macopharma, Genesis BPS, SURU International Pvt. Ltd., Shanghai Transfusion Technology Co., Ltd., Nigale Biomedical Inc. of Sichuan Province Corporation (Nigale), Neomedic Limited, and Shandong Weigao Group Medical Polymer Company Limited.
Source: P&S Intelligence